RTW Biotech Opportunities Ltd
RTWFF
$2.00
$0.073.63%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 322.16% | 422.09% | 580.81% | 364.19% | 96.37% |
| Total Revenue | 322.16% | 422.09% | 580.81% | 364.19% | 96.37% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 322.16% | 422.09% | 580.81% | 364.19% | 96.37% |
| SG&A Expenses | 7.39% | 22.84% | 43.18% | 54.55% | 69.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.58% | 27.43% | 47.16% | 57.10% | 69.82% |
| Operating Income | 625.92% | 633.31% | 640.64% | 352.57% | -32.77% |
| Income Before Tax | 617.36% | -10.48% | -167.67% | -126.49% | -58.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 617.36% | -10.48% | -167.67% | -126.49% | -58.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 617.36% | -10.48% | -167.67% | -126.49% | -58.91% |
| EBIT | 625.92% | 633.31% | 640.64% | 352.57% | -32.77% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 639.29% | -20.53% | -155.84% | -119.70% | -74.15% |
| Normalized Basic EPS | 96.83% | -18.46% | -120.05% | 52.88% | 258.82% |
| EPS Diluted | 639.29% | -20.53% | -155.84% | -119.70% | -74.15% |
| Normalized Diluted EPS | 96.83% | -18.46% | -120.05% | 52.88% | 258.82% |
| Average Basic Shares Outstanding | -2.23% | 8.58% | 21.86% | 37.95% | 58.72% |
| Average Diluted Shares Outstanding | -2.23% | 8.58% | 21.86% | 37.95% | 58.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |